Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00161863 | Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years | PHASE3 | COMPLETED | - | — | — | Sep 1, 2002 | Jan 1, 2003 | May 21, 2015 | 8 | Austria, Germany +1 |
| Name | Type | Description |
|---|---|---|
| FSME-IMMUN NEW 0.25 ml | BIOLOGICAL | - |
Inclusion Criteria: Male and female children and adolescents will be eligible for participation in this study if: * they are aged 1 year (from the 1st birthday) to \< 16 years (to the last day before the 16th birthday); * they are clinically healthy, (i. e. the physician would have no reservations...